Details
Stereochemistry | RACEMIC |
Molecular Formula | C21H27N |
Molecular Weight | 293.4466 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CC1c2ccccc2CCc3ccccc31)CN(C)C
InChI
InChIKey=ALELTFCQZDXAMQ-UHFFFAOYSA-N
InChI=1S/C21H27N/c1-16(15-22(2)3)14-21-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)21/h4-11,16,21H,12-15H2,1-3H3
Molecular Formula | C21H27N |
Molecular Weight | 293.4466 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1036481
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1036481
Butriptyline is a tricyclic antidepressant used in patients with depression associated with anxiety. The drug is supposed to be withdrawn from the market as the last publication about its clinical use is dated by 1988.
CNS Activity
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1036481
The daily dosage is between 75 and 150 mg/day.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/408861
Butriptyline exhibited rather potent inhibition of 3H-dopamine uptake in rat corpus striatum with IC50 value in the range 10(-6)-10(-5) M.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 16:23:51 UTC 2021
by
admin
on
Sat Jun 26 16:23:51 UTC 2021
|
Record UNII |
Z22441975X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QN06AA15
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
||
|
NCI_THESAURUS |
C265
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
||
|
WHO-ATC |
N06AA15
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
21772
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY | |||
|
19895
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY | RxNorm | ||
|
DB09016
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY | |||
|
SUB13137MIG
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY | |||
|
Z22441975X
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY | |||
|
35941-65-2
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY | |||
|
C79855
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY | |||
|
455
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY | |||
|
M2805
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY | Merck Index | ||
|
2123
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY | |||
|
BUTRIPTYLINE
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY | |||
|
CHEMBL2110816
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY | |||
|
35941-65-2
Created by
admin on Sat Jun 26 16:23:52 UTC 2021 , Edited by admin on Sat Jun 26 16:23:52 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |